![Sandesh Seth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandesh Seth
Chief Executive Officer at
ACTINIUM PHARMACEUTICALS, INC.
Net worth: 232 446 $ as of 2026-05-30
Profile
Sandesh Seth is currently Chairman, Chief Executive & Financial Officer at Actinium Pharmaceuticals, Inc. since 2026 and Managing Partner at Jamess Capital Group LLC.
Former roles include Chairman at Relmada Therapeutics, Inc. from 2015 to 2017, Director at Actinium Pharmaceuticals, Inc., Director at Cactus Ventures, Inc. from 2012 to 2013, Lead Director at Camp Nine, Inc., Director at Relmada Therapeutics, Inc. from 2012 to 2014, and Head-Healthcare Investment Banking at Laidlaw & Co. (UK) Ltd. Education includes an MBA from New York University and an undergraduate degree from the University of Mumbai.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-10-14 | 184,481 ( 0.59% ) | 232 446 $ | 2026-05-30 |
Sandesh Seth active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 2017-06-08 |
Jamess Capital Group LLC | Corporate Officer/Principal | - |
Former positions of Sandesh Seth
| Companies | Position | End |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chairman | 2017-06-05 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 2015-06-30 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Director/Board Member | 2013-04-17 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Director/Board Member | 2013-04-17 |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Director/Board Member | - |
Training of Sandesh Seth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
38
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Jamess Capital Group LLC | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
- Stock Market
- Insiders
- Sandesh Seth
